Pilot Study to Evaluate the Efficacy of Autogenic Training in Reducing Anxiety and Enhancing Quality of Life Among Mothers of Children with Special Needs
Abstract
Pain is a common major symptom of advanced cancer and over the years numerous agents and methods have been developed for pain control. However, not all patients would respond to treatment, and of those that respond, many would develop drug resistance or intolerable side effects. This is a review of some simple unconventional agents and methods which might hopefully bring some relief to the sufferings of these unfortunate patients. These include the revival of an abandoned old drug like thalidomide, unconventional route of administration of the common paracetamol and the uncommon use of botulinum toxin, the unconventional exploitation of methylnaltrexone in conjunction with opioids, the potential of a newcomer, suzetrigine and a brief review of complementary medicine. It is hoped that judicious application of these agents might bring more relief of pain and suffering to some of the advanced cancer patients.
Read the paper
Related studies
- Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 min
- De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus)
- Molecular Characterization and Expression Profiling of Tomato GRF Transcription Factor Family Genes in Response to Abiotic Stresses and Phytohormones
- Assembly of Tight Junction Strands: Claudin-10b and Claudin-3 Form Homo Tetrameric Building Blocks that Polymerise in a Channel-Independent Manner
- Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease‐associated variants, common sequence variants, and results from newborn screening
- Machine Learning-Based SERS Chemical Space for Two-Way Prediction of Structures and Spectra of Untrained Molecules
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.